1244 — 3D Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for 3D Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	824	942	997	841	438
Net Total Accounts Receivable
Net Total Receivables	72.3	156	85	127	102
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	919	1,143	1,095	988	557
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	119	178	193	148	138
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,060	1,332	1,429	1,216	936
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,248	376	500	488	385
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	3,298	389	492	431	340
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-2,238	943	937	785	597
Total Liabilities & Shareholders' Equity	1,060	1,332	1,429	1,216	936
Total Common Shares Outstanding